Opioid Development Strategies In Pediatrics To Get FDA Advisory Panel Help

While FDA has long required pediatric analgesic studies, very few sponsors have managed to complete them, mainly due to enrollment challenges; advisory committees will offer recommendations on other designs that may bring a more successful result.